ursolic acid has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bang, Y; Choi, HJ; Jung, K; Kim, M; Kwon, Y; Moon, SH | 1 |
| Birla, H; Dilnashin, H; Keswani, C; Rai, SN; Rathore, AS; Singh, R; Singh, RK; Singh, SP; Singh, SS; Zahra, W | 1 |
| Rai, SN; Singh, D; Singh, SP; Yadav, SK | 1 |
3 other study(ies) available for ursolic acid and Parkinson Disease
| Article | Year |
|---|---|
Ursolic acid enhances autophagic clearance and ameliorates motor and non-motor symptoms in Parkinson's disease mice model.
Topics: Animals; Autophagy; Humans; Mice; Neuroblastoma; Parkinson Disease; Rotenone; Ubiquitins; Ursolic Acid | 2023 |
Neuroprotection of Rotenone-Induced Parkinsonism by Ursolic Acid in PD Mouse Model.
Topics: alpha-Synuclein; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Disease Models, Animal; Dopaminergic Neurons; Male; Mice; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Parkinsonian Disorders; Rotenone; Triterpenes; Ursolic Acid | 2020 |
Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Corpus Striatum; Dopamine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Homovanillic Acid; Male; Mice; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Pars Compacta; Substantia Nigra; Triterpenes; Tyrosine 3-Monooxygenase; Ursolic Acid | 2016 |